Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 2341-2360 of 3,190 trials

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

NCT00720356

RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving bevacizumab together with erlotinib may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving bevacizumab together with erlotinib works after radiation therapy and temozolomide in treating patients with newly diagnosed glioblastoma multiforme or gliosarcoma.

Brain and Central Nervous System Tumors

Northwestern University115 participantsStarted Jul 2009

Los Angeles, California, United States • Orlando, Florida, United States • Chicago, Illinois, United States +6 more locations

TERMINATEDPhase 4< 1 mile

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

NCT02680847

Safety and pharmacokinetics of an abuse-deterrent, extended-release formulation of oxycodone hydrochloride with a sequestered naltrexone core in children 7-17 with moderate-severe pain.

Moderate-severe Pain

Pfizer32 participantsStarted Jan 2016

Lancaster, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +13 more locations

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

Rheumatoid Arthritis Trials in Other Cities

Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain

Post-Market Study of the Modular Revision Hip System

Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis

Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis

Assessing Fitting Guides in Alcon Multifocal Contact Lenses

Multicenter Continuous Peripheral Nerve Block Surveillance Study

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods

Immunogenicity of Off-Schedule Dosing of HPV Vaccine

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

Other Conditions in Los Angeles